Coya Therapeutics Income Statement (2021-2026) | COYA

Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 6.00M0.13M3.43M0.00M0.26M0.16M3.56M3.96M0.25M
Operating items
Research & Development (Quarter) 0.98M1.45M1.28M0.71M1.23M1.07M1.59M1.61M3.14M4.57M2.22M1.94M5.21M3.66M2.92M4.94M4.10M
Selling, General & Administrative (Quarter) 0.72M1.99M1.24M0.90M1.66M1.83M1.96M2.38M2.44M2.09M2.22M2.14M2.71M2.91M2.56M3.27M3.78M
Restructuring Costs (Quarter) 1.50M1.05M1.08M0.99M1.33M1.55M1.18M1.48M1.29M
Other Operating Expenses (Quarter) 0.00M0.00M0.15M0.40M0.01M0.36M0.01M0.20M-1.46M-1.04M-1.07M-0.99M-1.33M-1.54M-0.66M0.30M-1.28M
Operating Expenses (Quarter) 1.70M3.45M2.66M2.00M2.90M3.25M3.56M4.19M5.61M6.66M4.45M4.08M7.93M6.58M6.00M9.99M7.89M
Operating Income (Quarter) -1.70M-3.45M-2.66M-2.00M-2.90M-3.25M-3.56M1.82M-5.48M-3.24M-4.45M-4.08M-7.68M-6.41M-2.43M-6.03M-7.64M
EBIT (Quarter) -1.70M-3.45M-2.66M-2.00M-2.90M-3.25M-3.56M1.82M-5.48M-3.24M-4.45M-4.08M-7.68M-6.41M-2.43M-6.03M-7.64M
Non-operating items
Other Non Operating Income (Quarter) -0.00M0.01M0.04M0.02M0.16M0.16M0.14M0.17M0.43M0.34M0.43M0.44M0.37M0.32M0.32M0.33M0.43M
Net income details
EBT (Quarter) -1.70M-3.45M-2.66M-3.00M-3.98M-4.44M-4.53M-3.81M-5.05M-2.89M-8.36M-12.21M-7.31M-6.09M-4.86M-8.57M-7.21M
Profit After Tax (Quarter) -1.70M-3.41M-4.02M-3.11M-2.74M-3.10M-3.42M1.27M-5.05M-2.89M-4.02M-2.92M-7.31M-6.09M-2.12M-5.71M-7.21M
Income from Continuing Operations (Quarter) -1.70M-3.45M-2.66M-3.00M-3.98M-4.44M-4.53M-3.81M-5.05M-2.89M-8.36M-12.21M-7.31M-6.09M-4.86M-8.57M-7.21M
Consolidated Net Income (Quarter) -1.70M-3.45M-2.66M-3.00M-3.98M-4.44M-4.53M-3.81M-5.05M-2.89M-8.36M-12.21M-7.31M-6.09M-4.86M-8.57M-7.21M
Income towards Parent Company (Quarter) -1.70M-3.45M-2.66M-3.00M-3.98M-4.44M-4.53M-3.81M-5.05M-2.89M-8.36M-12.21M-7.31M-6.09M-4.86M-8.57M-7.21M
Net Income towards Common Stockholders (Quarter) -1.70M-3.45M-2.66M-3.00M-3.98M-4.44M-4.53M-3.81M-5.05M-2.89M-8.36M-12.21M-7.31M-6.09M-4.86M-8.57M-7.21M
Additional items
EPS (Basic) (Quarter) -0.66-1.33-1.03-1.16-0.41-0.45-0.46-0.37-0.35-0.19-0.55-0.80-0.44-0.36-0.29-0.51-0.32
EPS (Diluted) (Quarter) -0.66-1.33-1.03-1.16-0.41-0.45-0.46-0.37-0.35-0.19-0.55-0.80-0.44-0.36-0.29-0.51-0.32
Shares Outstanding (Quarter) 2.59M2.59M2.59M2.59M2.59M9.72M9.95M9.95M10.16M14.46M14.92M15.22M15.24M16.72M16.72M16.73M16.73M22.64M
Shares Outstanding (Diluted) (Quarter) 2.59M2.59M2.59M2.59M2.59M9.72M9.95M9.95M10.16M14.46M14.92M15.22M15.24M16.72M16.72M16.73M16.73M22.64M
EBITDA (Quarter) -1.70M-3.45M-2.66M-2.00M-2.90M-3.25M-3.56M1.82M-5.48M-3.24M-4.45M-4.08M-7.68M-6.41M-2.43M-6.03M-7.64M
Interest Expenses (Quarter) 1.14M1.00M1.08M1.18M0.97M5.63M9.75M3.26M3.91M8.13M4.18M2.56M2.43M2.54M0.60M